Nanosphere's Q1 Top Line Hit by Lower Contract Revenue | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere today reported that its first-quarter revenues declined, as contract revenue from the first quarter of 2010 was much higher than in 2011, but its product sales increased 31 percent.

The Northbrook, Ill.-based molecular diagnostics firm brought in total revenues of $640,000 for the three-month period ended March 31, down from $826,000 for Q1 2010. Nanosphere missed analysts' consensus estimate for revenues of $940,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.